Literature DB >> 23792476

Lactobacillus fermentum, a pathogen in documented cholecystitis.

Josue Chery1, Dmitriy Dvoskin, Fernando P Morato, Bashar Fahoum.   

Abstract

INTRODUCTION: Lactobacillus species are probiotics proven to exhibit various preventative as well as therapeutic properties. While lactobacillus species have been implicated in the formation of dental caries, endocarditis and bacteremia, their role as pathogens in cholecystitis has not been reported. We present a rare case of Lactobacillus fermentum working as a pathogen in cholecystitis. PRESENTATION OF CASE: An 81-year old male was admitted with right upper quadrant abdominal pain. His signs, symptoms, laboratory values and imaging were consistent with a diagnosis of cholecystitis with ascending cholangitis. In view of his co-morbidity and severe sepsis, the patient was treated non-operatively with antibiotics and cholecystostomy. L. fermentum, which was vancomycin resistant, was identified from the cholecystostomy aspirate and from anaerobic blood culture. The patient went into septic shock, developed multi-organ dysfunction syndrome and eventually died. DISCUSSION: Commensal bacteria such as L. fermentum are known to modulate immunity, reduce the pathogenicity of gastrointestinal organisms and play a therapeutic role in various disease processes. We isolated L. fermentum as a pathogen in a documented case of cholecystitis with ascending cholangitis.
CONCLUSION: While the routine use lactobacillus species as a probiotic is supported in the literature, understanding its potential role as a pathogen may allow more judicious use of these bacteria and encourage research to elucidate the pathogenicity of lactobacillus species.
Copyright © 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholangitis; Cholecystitis; Lactobacillus; Multi-organ dysfunction syndrome; Pathogenicity; Probiotic

Year:  2013        PMID: 23792476      PMCID: PMC3710909          DOI: 10.1016/j.ijscr.2013.04.034

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  21 in total

1.  Modulating immune responses with probiotic bacteria.

Authors:  T Matsuzaki; J Chin
Journal:  Immunol Cell Biol       Date:  2000-02       Impact factor: 5.126

2.  [Early vs conservative treatment of acute cholecystitis. Personal experience and review of the literature].

Authors:  M Ranalli; W Testi; A Genovese; C Bing; S Tumbiolo; E Andolfi; F Tani; G Botta
Journal:  Minerva Chir       Date:  2004-12       Impact factor: 1.000

Review 3.  Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Gregoria I Betsi; Theodoros Tokas; Stavros Athanasiou
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: two probiotic strains isolated from human breast milk.

Authors:  Francisco J Pérez-Cano; Honglin Dong; Parveen Yaqoob
Journal:  Immunobiology       Date:  2010-02-06       Impact factor: 3.144

5.  Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats.

Authors:  Bing Siang Gan; Juan Kim; Gregor Reid; Peter Cadieux; Jeffrey C Howard
Journal:  J Infect Dis       Date:  2002-04-05       Impact factor: 5.226

6.  Non-operative management of acute cholecystitis in the elderly.

Authors:  E A McGillicuddy; K M Schuster; K Barre; L Suarez; M R Hall; G J Kaml; K A Davis; W E Longo
Journal:  Br J Surg       Date:  2012-07-24       Impact factor: 6.939

7.  Lactobacillus fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens.

Authors:  Parvathi Varma; Kavitha R Dinesh; Krishna K Menon; Raja Biswas
Journal:  J Food Sci       Date:  2010-10-07       Impact factor: 3.167

8.  Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG.

Authors:  Minna K Salminen; Hilpi Rautelin; Soile Tynkkynen; Tuija Poussa; Maija Saxelin; Ville Valtonen; Asko Järvinen
Journal:  Clin Infect Dis       Date:  2003-12-04       Impact factor: 9.079

Review 9.  Diagnosis and management of cholecystitis and cholangitis.

Authors:  Ian F Yusoff; Jeffrey S Barkun; Alan N Barkun
Journal:  Gastroenterol Clin North Am       Date:  2003-12       Impact factor: 3.806

Review 10.  Probiotics for the treatment of women with bacterial vaginosis.

Authors:  M E Falagas; G I Betsi; S Athanasiou
Journal:  Clin Microbiol Infect       Date:  2007-07       Impact factor: 8.067

View more
  3 in total

1.  Answer to March 2018 Photo Quiz.

Authors:  Raúl Recio; Patricia Brañas; Fernando Chaves; M Ángeles Orellana
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Acute Cholecystitis Complicated with Gallbladder Perforation and Peritonitis Caused by Vancomycin-resistant Lactobacillus paracasei.

Authors:  Christina Lee; Nicha Wongjarupong; Muthu Narayan; Anne C Melzer
Journal:  Cureus       Date:  2020-03-30

Review 3.  Probiotics: Should All Patients Take Them?

Authors:  Marta Katkowska; Katarzyna Garbacz; Aida Kusiak
Journal:  Microorganisms       Date:  2021-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.